Maryland-based Emergent BioSolutions, which is recovering from regulatory woes in the wake of COVID-19 vaccine production problems, has elevated Deputy General Counsel Jennifer Fox to general counsel.

Fox, who joined Emergent in 2018 as an associate general counsel, will now serve as executive vice president, external affairs, general counsel, and corporate secretary. She replaces Atul Saran, executive vice president and general counsel. Saran now will serve as chief strategy and development officer.